These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32273089)

  • 1. Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6/STAT3 inflammatory pathway-maintained cancer stemness.
    Gong T; Zhang P; Jia L; Pan Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):820-826. PubMed ID: 32273089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy of differentiation therapy: effect of dual-frequency ultrasound on the induction of liver cancer stem-like cells on a HA-based multilayer film system.
    Lee IC; Fadera S; Liu HL
    J Mater Chem B; 2019 Sep; 7(35):5401-5411. PubMed ID: 31414097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
    Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
    Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
    Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
    J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
    Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
    Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
    Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J
    BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.
    Jiang YX; Siu MK; Wang JJ; Mo XT; Leung TH; Chan DW; Cheung AN; Ngan HY; Chan KK
    Br J Cancer; 2020 Jul; 123(2):275-287. PubMed ID: 32390009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
    Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.
    Kim SY; Kang JW; Song X; Kim BK; Yoo YD; Kwon YT; Lee YJ
    Cell Signal; 2013 Apr; 25(4):961-9. PubMed ID: 23333246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.
    Li X; Wang J; Wu W; Gao H; Liu N; Zhan G; Li L; Han L; Guo X
    FEBS J; 2020 Dec; 287(23):5218-5235. PubMed ID: 32239647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
    Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
    Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
    Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
    Guo YQ; Lu P; Duan ZF; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer.
    Yan M; Han M; Yang X; Shen R; Wang H; Zhang L; Xia S; Yang P; Zhai G; Shao Q
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1905-1915. PubMed ID: 34369236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.